Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 4Head & Neck 3Genitourinary 3Gastrointestinal 3

Conditions

Carcinoma, Renal Cell 17Melanoma 16Kidney Neoplasms 11Neoplasm Metastasis 10Uterine Cervical Neoplasms 9Prostatic Neoplasms 9Breast Neoplasms 7Ovarian Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Anus Neoplasms 6Vaginal Neoplasms 5Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Penile Neoplasms 5Pancreatic Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Oropharyngeal Neoplasms 4Lymphoma 4Lung Neoplasms 4Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Vulvar Neoplasms 3Neuroblastoma 3Multiple Myeloma 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Wilms Tumor 2

Interventions

fludarabine 3Radiotherapy 3Cyclophosphamide 3entinostat 2aldesleukin 2aflibercept 2Trastuzumab 2Nivolumab 2Adoptive Transfer 2trastuzumab deruxtecan 1tivozanib 1tipifarnib 1rocakinogene sifuplasmid 1pembrolizumab 1oncogene protein E7, Human papillomavirus type 16 1durvalumab 1bintrafusp alfa protein, human 1atezolizumab 1Vorinostat 1VGX-3100 1Specimen Handling 1Ritonavir 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1MEDI0457 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vulvar Neoplasms × fludarabine × Genitourinary × Clear all
NCT06505551 2024-07-17

Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma

SCG Cell Therapy Pte. Ltd.

Phase 1/2 Not yet recruiting
66 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05787535 2024-02-02

HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor

HRYZ Biotech Co.

Phase 1 Unknown
17 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05952947 2024-02-02

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

HRYZ Biotech Co.

Phase 1 Recruiting
32 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡